PEAR Insider Trading

Insider Ownership Percentage: 30.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,839,319.76

Pear Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Pear Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pear Therapeutics Share Price & Price History

Current Price: $0.34
Price Change: Price Increase of +0.1255 (59.88%)
As of 03/21/2023 05:00 PM ET

This chart shows the closing price history over time for PEAR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Pear Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/20/2023Christopherd T GuiffreCFOSell19,540$1.13$22,080.2029,960View SEC Filing Icon  
1/20/2023Corey MccannCEOSell34,731$1.13$39,246.038,210,834View SEC Filing Icon  
1/20/2023Ellen SnowCAOSell8,027$1.13$9,070.5123,318View SEC Filing Icon  
1/20/2023Ronan O'brienInsiderSell12,162$1.13$13,743.0618,638View SEC Filing Icon  
11/14/20225Am Partners Iv, LlcMajor ShareholderSell12,128$2.79$33,837.12537,406View SEC Filing Icon  
11/11/20225Am Partners Iv, LlcMajor ShareholderSell29,380$3.19$93,722.20537,891View SEC Filing Icon  
11/2/20225Am Partners Iv, LlcMajor ShareholderSell10,578$2.72$28,772.16539,066View SEC Filing Icon  
10/31/20225Am Partners Iv, LlcMajor ShareholderSell42,164$2.78$117,215.92539,548View SEC Filing Icon  
9/16/20225Am Partners Iv, LlcMajor ShareholderSell351$1.75$614.25541,235View SEC Filing Icon  
9/14/20225Am Partners Iv, LlcMajor ShareholderSell285,067$1.94$553,029.98552,159View SEC Filing Icon  
9/8/20225Am Partners Iv, LlcMajor ShareholderSell304,322$1.81$550,822.82563,562View SEC Filing Icon  
9/6/20225Am Partners Iv, LlcMajor ShareholderSell311,160$2.36$734,337.60581,916View SEC Filing Icon  
8/18/20225Am Partners Iv, LlcMajor ShareholderSell222,761$1.55$345,279.55594,362View SEC Filing Icon  
8/16/20225Am Partners Iv, LlcMajor ShareholderSell167,162$1.78$297,548.36603,675View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Pear Therapeutics (NASDAQ:PEAR)

71.17% of Pear Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PEAR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Pear Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023MetLife Investment Management LLC41,941$49K0.0%N/A0.030%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC44,943$53K0.0%N/A0.032%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley53,560$63K0.0%+121.0%0.038%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP73,990$87K0.0%+262.0%0.053%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC32,300$38K0.0%-36.8%0.023%Search for SEC Filing on Google Icon
2/13/2023The Manufacturers Life Insurance Company 29,233$34K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC1,048,945$1.24M0.0%+1.3%0.749%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE49,329$58K0.0%+686.2%0.035%Search for SEC Filing on Google Icon
2/2/2023SG Americas Securities LLC25,676$30K0.0%+61.1%0.018%Search for SEC Filing on Google Icon
1/24/2023Darrow Company Inc.154,711$0.18M0.2%-15.1%0.110%Search for SEC Filing on Google Icon
12/8/2022Bank of New York Mellon Corp167,851$0.34M0.0%+1,310.6%0.120%Search for SEC Filing on Google Icon
11/21/2022California State Teachers Retirement System27,049$55K0.0%N/A0.019%Search for SEC Filing on Google Icon
11/16/2022BNP Paribas Arbitrage SNC24,697$50K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/15/2022State Street Corp923,012$1.88M0.0%+195.8%0.665%Search for SEC Filing on Google Icon
11/15/2022Verdence Capital Advisors LLC13,815$28K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.3,226,467$6.58M0.0%+203.0%2.325%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp167,851$0.34M0.0%+1,310.6%0.121%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.3,014,890$6.15M0.0%+603.2%2.173%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC51,100$0.10M0.0%-26.8%0.037%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC96,231$0.20M0.0%N/A0.069%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund48,590$99K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/3/2022Darrow Company Inc.182,211$0.37M0.4%N/A0.131%Search for SEC Filing on Google Icon
11/2/2022Daiwa Securities Group Inc.12,737$26K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC15,935$33K0.0%N/A0.011%Search for SEC Filing on Google Icon
10/27/2022US Bancorp DE54,897$0.11M0.0%N/A0.040%Search for SEC Filing on Google Icon
10/27/2022Strs Ohio15,900$32K0.0%N/A0.011%Search for SEC Filing on Google Icon
10/12/2022Acropolis Investment Management LLC164,842$0.34M0.0%N/A0.119%Search for SEC Filing on Google Icon
8/15/2022State Street Corp312,028$0.48M0.0%+296.4%0.226%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC248,399$0.38M0.0%+574.1%0.180%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC69,778$0.11M0.0%N/A0.051%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.91,969$0.14M0.0%+6,469.2%0.067%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE23,353$0.12M0.0%N/A0.017%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC32,352$0.16M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/17/2022Shay Capital LLC25,000$0.13M0.0%N/A0.018%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.15,620$79K0.0%N/A0.011%Search for SEC Filing on Google Icon
5/16/2022State Street Corp78,715$0.40M0.0%N/A0.057%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp61,895$0.31M0.0%N/A0.045%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.19,890$0.10M0.0%N/A0.014%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,045,443$5.28M0.0%+67.9%0.758%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.416,278$2.10M0.0%N/A0.302%Search for SEC Filing on Google Icon
5/12/2022Magnus Financial Group LLC11,800$60K0.0%N/A0.009%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp11,418$58K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP28,900$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
4/26/2022Sciencast Management LP36,621$0.19M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/25/2022EDBI Pte Ltd426,371$2.64M1.4%N/A1.236%Search for SEC Filing on Google Icon
2/14/2022Sarissa Capital Management LP500,356$3.10M0.3%N/A1.450%Search for SEC Filing on Google Icon
2/14/2022SB Global Advisers Ltd12,100,078$75.02M1.5%N/A35.073%Search for SEC Filing on Google Icon
2/9/2022Arboretum Ventures Inc.10,859,050$67.33M38.8%N/A31.476%Search for SEC Filing on Google Icon
2/7/2022Roble Belko & Company Inc4,502$28K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/3/20225AM Venture Management LLC18,631,771$115.52M21.7%N/A54.005%Search for SEC Filing on Google Icon
1/28/2022BerganKDV Wealth Management LLC4,500$28K0.0%N/A0.013%Search for SEC Filing on Google Icon
1/18/2022TB Alternative Assets Ltd.2,071,865$12.85M3.8%N/A25.233%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Pear Therapeutics logo
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
Read More on Pear Therapeutics

Today's Range

Now: $0.34
Low: $0.25
High: $0.48

50 Day Range

MA: $1.00
Low: $0.21
High: $1.24

52 Week Range

Now: $0.34
Low: $0.20
High: $6.74

Volume

20,426,164 shs

Average Volume

606,410 shs

Market Capitalization

$46.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Pear Therapeutics?

Pear Therapeutics' top insider shareholders include:
  1. Corey Mccann (CEO)
  2. 5Am Partners Iv, Llc (Major Shareholder)
  3. Christopherd T Guiffre (CFO)
  4. Ellen Snow (CAO)
  5. Ronan O'brien (Insider)
Learn More about top insider investors at Pear Therapeutics.

Who are the major institutional investors of Pear Therapeutics?

Pear Therapeutics' top institutional investors include:
  1. Geode Capital Management LLC — 0.75%
  2. Darrow Company Inc. — 0.11%
  3. Susquehanna International Group LLP — 0.05%
  4. Morgan Stanley — 0.04%
  5. Bank of America Corp DE — 0.04%
  6. Jane Street Group LLC — 0.03%
Learn More about top institutional investors of Pear Therapeutics stock.

Which major investors are selling Pear Therapeutics stock?

Within the previous quarter, PEAR stock was sold by these institutional investors:
  1. Darrow Company Inc.
  2. Renaissance Technologies LLC
During the last year, company insiders that have sold Pear Therapeutics company stock include:
  1. Corey Mccann (CEO)
  2. 5Am Partners Iv, Llc (Major Shareholder)
  3. Christopherd T Guiffre (CFO)
  4. Ellen Snow (CAO)
  5. Ronan O'brien (Insider)
Learn More investors selling Pear Therapeutics stock.

Which major investors are buying Pear Therapeutics stock?

During the last quarter, PEAR stock was acquired by institutional investors including:
  1. Susquehanna International Group LLP
  2. Jane Street Group LLC
  3. Bank of America Corp DE
  4. MetLife Investment Management LLC
  5. Morgan Stanley
  6. The Manufacturers Life Insurance Company
  7. Geode Capital Management LLC
  8. SG Americas Securities LLC